Yang Hu1, Karen H Costenbader1, Xiang Gao1, May Al-Daabil1, Jeffrey A Sparks1, Daniel H Solomon1, Frank B Hu1, Elizabeth W Karlson1, Bing Lu1. 1. From the Division of Rheumatology, Immunology, and Allergy (YH, KHC, DHS, EWK, MA-D, JAS, and BL) and the Channing Division of Network Medicine (FBH and XG), Brigham and Women's Hospital and Harvard Medical School, Boston, MA, and the Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA (FBH).
Abstract
BACKGROUND: Sugar-sweetened soda consumption is consistently associated with an increased risk of several chronic inflammatory diseases such as type 2 diabetes and cardiovascular diseases. Whether it plays a role in the development of rheumatoid arthritis (RA), a common autoimmune inflammatory disease, remains unclear. OBJECTIVE: The aim was to evaluate the association between sugar-sweetened soda consumption and risk of RA in US women. DESIGN: We prospectively followed 79,570 women from the Nurses' Health Study (NHS; 1980-2008) and 107,330 women from the NHS II (1991-2009). Information on sugar-sweetened soda consumption (including regular cola, caffeine-free cola, and other sugar-sweetened carbonated soda) was obtained from a validated food-frequency questionnaire at baseline and approximately every 4 y during follow-up. Incident RA cases were validated by medical record review. Time-varying Cox proportional hazards regression models were used to calculate HRs after adjustment for confounders. Results from both cohorts were pooled by an inverse-variance-weighted, fixed-effects model. RESULTS: During 3,381,268 person-years of follow-up, 857 incident cases of RA were documented in the 2 cohorts. In the multivariable pooled analyses, we found that women who consumed ≥1 serving of sugar-sweetened soda/d had a 63% (HR: 1.63; 95% CI: 1.15, 2.30; P-trend = 0.004) increased risk of developing seropositive RA compared with those who consumed no sugar-sweetened soda or who consumed <1 serving/mo. When we restricted analyses to those with later RA onset (after age 55 y) in the NHS, the association appeared to be stronger (HR: 2.64; 95% CI: 1.56, 4.46; P-trend < 0.0001). No significant association was found for sugar-sweetened soda and seronegative RA. Diet soda consumption was not significantly associated with risk of RA in the 2 cohorts. CONCLUSION: Regular consumption of sugar-sweetened soda, but not diet soda, is associated with increased risk of seropositive RA in women, independent of other dietary and lifestyle factors.
BACKGROUND:Sugar-sweetened soda consumption is consistently associated with an increased risk of several chronic inflammatory diseases such as type 2 diabetes and cardiovascular diseases. Whether it plays a role in the development of rheumatoid arthritis (RA), a common autoimmune inflammatory disease, remains unclear. OBJECTIVE: The aim was to evaluate the association between sugar-sweetened soda consumption and risk of RA in US women. DESIGN: We prospectively followed 79,570 women from the Nurses' Health Study (NHS; 1980-2008) and 107,330 women from the NHS II (1991-2009). Information on sugar-sweetened soda consumption (including regular cola, caffeine-free cola, and other sugar-sweetened carbonated soda) was obtained from a validated food-frequency questionnaire at baseline and approximately every 4 y during follow-up. Incident RA cases were validated by medical record review. Time-varying Cox proportional hazards regression models were used to calculate HRs after adjustment for confounders. Results from both cohorts were pooled by an inverse-variance-weighted, fixed-effects model. RESULTS: During 3,381,268 person-years of follow-up, 857 incident cases of RA were documented in the 2 cohorts. In the multivariable pooled analyses, we found that women who consumed ≥1 serving of sugar-sweetened soda/d had a 63% (HR: 1.63; 95% CI: 1.15, 2.30; P-trend = 0.004) increased risk of developing seropositive RA compared with those who consumed no sugar-sweetened soda or who consumed <1 serving/mo. When we restricted analyses to those with later RA onset (after age 55 y) in the NHS, the association appeared to be stronger (HR: 2.64; 95% CI: 1.56, 4.46; P-trend < 0.0001). No significant association was found for sugar-sweetened soda and seronegative RA. Diet soda consumption was not significantly associated with risk of RA in the 2 cohorts. CONCLUSION: Regular consumption of sugar-sweetened soda, but not diet soda, is associated with increased risk of seropositive RA in women, independent of other dietary and lifestyle factors.
Authors: Simin Liu; JoAnn E Manson; Julie E Buring; Meir J Stampfer; Walter C Willett; Paul M Ridker Journal: Am J Clin Nutr Date: 2002-03 Impact factor: 7.045
Authors: Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Ingrid Avalos; Tuulikki Sokka; Paolo Raggi; Theodore Pincus; C Michael Stein Journal: Arthritis Rheum Date: 2008-07
Authors: Elizabeth W Karlson; Lori B Chibnik; Shelley S Tworoger; I-Min Lee; Julie E Buring; Nancy A Shadick; Joann E Manson; Karen H Costenbader Journal: Arthritis Rheum Date: 2009-03
Authors: Jaime E Hart; Francine Laden; Robin C Puett; Karen H Costenbader; Elizabeth W Karlson Journal: Environ Health Perspect Date: 2009-03-04 Impact factor: 9.031
Authors: Sara K Tedeschi; Michelle Frits; Jing Cui; Zhi Zack Zhang; Taysir Mahmoud; Christine Iannaccone; Tzu-Chieh Lin; Kazuki Yoshida; Michael E Weinblatt; Nancy A Shadick; Daniel H Solomon Journal: Arthritis Care Res (Hoboken) Date: 2017-12 Impact factor: 4.794
Authors: Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers Journal: Best Pract Res Clin Rheumatol Date: 2017-09-18 Impact factor: 4.098
Authors: Yang Hu; Jeffrey A Sparks; Susan Malspeis; Karen H Costenbader; Frank B Hu; Elizabeth W Karlson; Bing Lu Journal: Ann Rheum Dis Date: 2017-01-30 Impact factor: 19.103
Authors: Jeffrey A Sparks; Shun-Chiao Chang; Kevin D Deane; Ryan W Gan; M Kristen Demoruelle; Marie L Feser; LauraKay Moss; Jane H Buckner; Richard M Keating; Karen H Costenbader; Peter K Gregersen; Michael H Weisman; Ted R Mikuls; James R O'Dell; V Michael Holers; Jill M Norris; Elizabeth W Karlson Journal: Arthritis Rheumatol Date: 2016-08 Impact factor: 10.995
Authors: Jeffrey A Sparks; Maura D Iversen; Zhi Yu; Nellie A Triedman; Maria G Prado; Rachel Miller Kroouze; Sarah S Kalia; Michael L Atkinson; Elinor A Mody; Simon M Helfgott; Derrick J Todd; Paul F Dellaripa; Bonnie L Bermas; Karen H Costenbader; Kevin D Deane; Bing Lu; Robert C Green; Elizabeth W Karlson Journal: Arthritis Care Res (Hoboken) Date: 2018-04-16 Impact factor: 4.794